Wed, Dec 24, 2014, 7:17 PM EST - U.S. Markets closed early today


% | $
Quotes you view appear here for quick access.

Omeros Corporation (OMER) Message Board

  • rrtzrealmd rrtzrealmd Apr 30, 2013 10:44 AM Flag

    HAW!!!...looks like its time for yet ANOTHER....

    ...MEANINGLESS press release!!!...HAW!...this time they say:

    "...confirmed that the Company's planned Marketing Authorization Application (MAA) for its ophthalmology product OMS302 can be submitted and reviewed under the EMA's centralized procedure."

    ...well, bless the EMA's heart!...that was so kind of them to allow GOMER to actually file an application for consideration at a future time in a galaxy far, far, away...

    ...speaking of applications, wasn't GOMER supposed to have submitted some kind of NDA for OMS302 to the FDA?...they seem to be running a mite slow on that issue, don't you think?...

    ...maybe they're worried about what they'll say when the FDA asks what benefits does OMS302 confer versus already available generic eyedrops....coming up with some good answers to that question might cause some serious consternation amongst all those well paid GOMER scientists...

    ...well, we're bound to find out sooner or later...presuming, of course, we can survive the deluge of meaningless press the way, GOMER's down about a dime as I type this -- I reckon the street knows a meaningless press release when it sees one, huh?...

    ....HAW, HAW, HAW!!!!...

    Sentiment: Strong Sell

22.09+0.48(+2.22%)Dec 24 12:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.